We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8233:TSETakashimaya Company, Limited Analysis

Data as of 2026-03-15 - not real-time

¥1,806.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Takashimaya is trading at 1,806 JPY, sitting below its 20‑day SMA of 2,021 and 50‑day SMA of 1,977, indicating short‑term price weakness despite a bullish overall trend flag. The RSI of 36 suggests the stock is approaching oversold territory, while the MACD histogram remains negative, signaling lingering bearish momentum. Support at 1,716.5 JPY provides a cushion, and the nearest resistance at 2,405.5 JPY is far above current levels, limiting immediate upside. Volatility is elevated at ~48% over the past 30 days, but beta is low (≈0.32), implying limited market‑wide swing. Fundamental metrics show a PE of 15.7, forward PE 13.7, and a price‑to‑book of 1.11, placing valuation near fair. Dividend yield of 1.88% with a 26% payout ratio and strong operating cash flow support dividend sustainability.
However, revenue is contracting (-1.6% YoY) and debt‑to‑equity is high at 67, which tempers growth prospects and adds balance‑sheet risk. The company’s ROE of 8.9% and free cash flow generation provide a modest cushion, but the sector’s consumer‑cyclical nature makes earnings sensitive to economic cycles. Given the mixed technical signals and solid but not spectacular fundamentals, the stock appears fairly valued with limited near‑term catalysts, while dividend income offers a defensive edge.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • RSI near oversold level
  • Negative MACD histogram
  • Proximity to support at 1,716.5 JPY

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Fair valuation with forward PE under 15
  • Sustainable dividend yield
  • Bullish longer‑term trend indicated by SMA hierarchy

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt‑to‑equity ratio
  • Revenue contraction
  • Stable cash flow and dividend sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth-1.60%
Profit Margin10.72%
P/E Ratio15.7
ROE8.92%
ROA2.52%
Debt/Equity67.26
P/B Ratio1.1
Op. Cash Flow¥64.5B
Free Cash Flow¥16.9B

Technical Analysis

TrendBullish
RSI36.5
Support¥1,716.50
Resistance¥2,405.50
MA 20¥2,021.10
MA 50¥1,976.91
MA 200¥1,550.63
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Target Price¥1,877.50
Upside/Downside3.96%
GradeFair
TypeValue
Dividend Yield1.88%

Risk Assessment

Beta0.32
Volatility48.37%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.